Targeting glutamine dependence with DRP-104 inhibits proliferation and tumor growth of castration-resistant prostate cancer.
Prostate
; 84(4): 349-357, 2024 Mar.
Article
in En
| MEDLINE
| ID: mdl-38084059
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prodrugs
/
Prostatic Neoplasms, Castration-Resistant
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Prostate
Year:
2024
Document type:
Article
Affiliation country:
United States
Country of publication:
United States